Literature DB >> 3872591

Subendocardial resection for sustained ventricular tachycardia in the early period after acute myocardial infarction.

J M Miller, F E Marchlinski, A H Harken, W C Hargrove, M E Josephson.   

Abstract

One hundred nineteen patients with drug-refractory ventricular tachycardia (VT) underwent mapping-guided subendocardial resection for control of their arrhythmias from 3 weeks to 10 years after acute myocardial infarction (AMI). Patients were separated into 2 groups: those treated early (within 4 months, group I) and those treated later (after 1 year, group II) after AMI. There were 32 patients in group I and 72 patients in group II. Both groups of patients had similar clinical, angiographic and hemodynamic characteristics. Patients in group I had VT with a shorter mean cycle length than patients in group II (322 +/- 71 vs 349 +/- 88 ms, p less than 0.05). The groups did not differ with respect to operative mortality (12% vs 7%), late mortality (31% vs 33%, mean follow-up 23 months), or frequency with which subendocardial resection without any adjunctive therapy prevented postoperative spontaneous or inducible VT (21% vs 34%). Group I was further separated into patients who underwent subendocardial resection within 1 month of AMI (n = 7) and those who underwent subendocardial resection with 2 months of AMI (n = 14). Although patients in group I were characterized by having more spontaneous morphologically distinct tachycardias, their operative mortality, total mortality and surgical success rates were comparable to those of patients in group II.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3872591     DOI: 10.1016/0002-9149(85)90730-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Role of orthotopic heart transplantation in the management of patients with recurrent ventricular tachyarrhythmias following myocardial infarction.

Authors:  J P Bourke; A Loaiza; G Parry; C Hilton; S Furniss; J Dark; J Forty
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

Review 2.  Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.

Authors:  B P Betensky; F E Marchlinski
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

Review 3.  Decrement Evoked Potential Mapping to Guide Ventricular Tachycardia Ablation: Elucidating the Functional Substrate.

Authors:  Abhishek Bhaskaran; John Fitzgerald; Nicholas Jackson; Sigfus Gizurarson; Kumaraswamy Nanthakumar; Andreu Porta-Sánchez
Journal:  Arrhythm Electrophysiol Rev       Date:  2020-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.